May 2022
We’re changing how we cover some prescription drugs starting in July
What you need to know
Starting July 1, 2022, certain drugs associated with our prescription drug plans won’t be covered, while others will have a higher copayment.
Our goal at Blue Cross Blue Shield of Michigan and Blue Care Network is to provide our members with safe, high-quality prescription drug therapies. We continuously review prescription drugs to provide the best value for our members, control costs and make sure our members are using the right drug for the right situation.
Starting July 1, 2022, we’ll change how we cover some medications on the drug lists associated with our prescription drug plans. We’ll send letters to affected members, their groups and health care providers.
Drugs that won’t be covered
We’ll no longer cover the drugs on the following list. Unless noted, both the brand name and available generic equivalents won’t be covered. If members fill a prescription for one of these drugs on or after July 1, 2022, they’ll be responsible for the full cost.
The drugs that won’t be covered are listed below, along with suggested covered preferred alternatives that have similar effectiveness, quality and safety. When pharmacies fill prescriptions with preferred alternatives, the generic equivalents are dispensed, if available. Additional coverage requirements may apply for preferred alternatives, such as prior authorization.
Drugs that won’t be covered |
Common use or drug class |
Preferred alternatives |
Glucagon emergency kit (brand only) |
Hypoglycemia |
Generic glucagon emergency kit, Baqsimi®, Gvoke®, Zegalogue® |
GlucaGen® HypoKit® |
Hypoglycemia |
Generic glucagon emergency kit, Baqsimi®, Gvoke®, Zegalogue® |
Praluent®** |
Hypercholesterolemia |
Repatha® |
Ilevro®*** |
Ophthalmic NSAIDs |
Generic bromfenac sodium (once daily), generic diclofenac sodium, generic flurbiprofen sodium, generic ketorolac tromethamine, Prolensa® |
Nevanac®** |
Ophthalmic NSAIDs |
Generic bromfenac sodium (once daily), generic diclofenac sodium, generic flurbiprofen sodium, generic ketorolac tromethamine, Prolensa® |
**Drug is already not covered for Preferred Drug List
***Drug is already not covered for Custom Select Drug List
Drugs that will have a higher copayment
The brand-name drugs that will have a higher copayment are listed, along with suggested covered preferred alternatives that have similar effectiveness, quality and safety. When pharmacies fill prescriptions with preferred alternatives, the generic equivalents are dispensed, if available. Additional coverage requirements may apply for preferred alternatives.
Nonpreferred drugs that will have a higher copayment
(or won’t be covered for members with a closed benefit)
|
Common use or drug class |
Preferred alternatives |
Nyvepria® |
Neutropenia |
Neulasta®, Ziextenzo®
(Step therapy through Neulasta® and Ziextenzo® will also be required for coverage of Nyvepria®.)
|
|